The SELUTION DeNovo Study
Selution DeNovo - A Prospective Randomized, Multi-centre, International, Open Label, Clinical Trial Comparing the Selution DEB Strategy Versus DES Strategy.
Sponsor: M.A. Med Alliance S.A.
This NA trial investigates Coronary Artery Disease and is currently ongoing. M.A. Med Alliance S.A. leads this study, which shows 12 recorded versions since 2021 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Oct 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
-
Apr 2023 — Nov 2023 [monthly]
Recruiting NA
-
Mar 2023 — Apr 2023 [monthly]
Recruiting NA
-
Feb 2022 — Mar 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- M.A. Med Alliance S.A.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alessandria, Italy , Amsterdam, Netherlands , Augsburg, Germany , Bad Krozingen, Germany , Barcelona, Spain , Basel, Switzerland , Berlin, Germany , Bern, Switzerland , Bournemouth, United Kingdom , Bremen, Germany and 48 more locations